Potato Resistant Starch Type 1 Promotes Obesity Linked with Modified Gut Microbiota in High-Fat Diet-Fed Mice

Weiyue Zhang,Nana Zhang,Xinxin Guo,Bei Fan,Shumei Cheng,Fengzhong Wang
DOI: https://doi.org/10.3390/molecules29020370
IF: 4.6
2024-01-12
Molecules
Abstract:Obesity has become a major disease that endangers human health. Studies have shown that dietary interventions can reduce the prevalence of obesity and diabetes. Resistant starch (RS) exerts anti-obesity effects, alleviates metabolic syndrome, and maintains intestinal health. However, different RS types have different physical and chemical properties. Current research on RS has focused mainly on RS types 2, 3, and 4, with few studies on RS1. Therefore, this study aimed to investigate the effect of RS1 on obesity and gut microbiota structure in mice. In this study, we investigated the effect of potato RS type 1 (PRS1) on obesity and inflammation. Mouse weights, as well as their food intake, blood glucose, and lipid indexes, were assessed, and inflammatory factors were measured in the blood and tissues of the mice. We also analyzed the expression levels of related genes using PCR, with 16S rRNA sequencing used to study intestinal microbiota changes in the mice. Finally, the level of short-chain fatty acids was determined. The results indicated that PRS1 promoted host obesity and weight gain and increased blood glucose and inflammatory cytokine levels by altering the gut microbiota structure.
chemistry, multidisciplinary,biochemistry & molecular biology
What problem does this paper attempt to address?
The problem this paper attempts to address is the impact of Potato Resistant Starch Type 1 (PRS1) on obese mice and its relationship with gut microbiota structure. Specifically, the study aims to explore how PRS1 affects obesity, inflammatory responses, and changes in gut microbiota in mice fed a high-fat diet. The research found that PRS1 not only promoted weight gain and increased blood glucose levels in mice but also led to elevated levels of inflammatory factors by altering the gut microbiota structure. Therefore, the focus of this study is to reveal the mechanism of PRS1 in obesity and related metabolic syndromes.